Các đột biến CDH1 ở dòng mầm trong một nhóm bệnh nhân Trung Quốc mắc ung thư dạ dày di truyền dạng lan tỏa

Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249. https://doi.org/10.1038/nmeth0410-248 Barber ME, Save V, Carneiro F et al (2008) Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol 216:286–294. https://doi.org/10.1002/path.2415 Benusiglio PR, Malka D, Rouleau E et al (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50:486–489. https://doi.org/10.1136/jmedgenet-2012-101472 Benusiglio PR, Colas C, Rouleau E et al (2015) Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation. J Med Genet 52(8):563–565. https://doi.org/10.1136/jmedgenet-2015-103153 Brenner H, Bode G, Boeing H (2000) Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 118:31–35. https://doi.org/10.1016/S0016-5085(00)70411-2 Caldas C, Carneiro HT, Lynch F et al (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36:873–880 Chen W, Zheng R, Baade P et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132. https://doi.org/10.3322/caac.21338 Choi H, Ki C, Suh S, Kim J (2014) Presymptomatic identification of CDH1 germline mutation in a healthy Korean individual with family history of gastric cancer. Ann Lab Med 34:386–389. https://doi.org/10.3343/alm.2014.34.5.386 Corso G, Pedrazzani C, Pinheiro H et al (2011) E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer 47:631–639. https://doi.org/10.1016/j.ejca.2010.10.011 Corso G, Marrelli D, Pascale V et al (2012) Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer 12:1–10. https://doi.org/10.1186/1471-2407-12-8 Corso G, Figueiredo J, Biffi R et al (2014) E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 33:1081–1094. https://doi.org/10.1007/s10555-014-9528-y Ferlay F, Parkin D, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781. https://doi.org/10.1016/j.ejca.2009.12.014 Ferlay F, Ervik M, Dikshit R et al (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No.11, International Agency for Research on Cancer Fitzgerald RC, Hardwick R, Huntsman D et al (2010) Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 47:436–444. https://doi.org/10.1136/jmg.2009.074237 Guilford P, Hopkins J, Harraway J et al (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405. https://doi.org/10.1038/32918 Hansford S, Kaurah P, Li-Chang H et al (2015) Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 1:23–32. https://doi.org/10.1001/jamaoncol.2014.168 Humar B, Guilford P (2009) Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 100:1151–1157. https://doi.org/10.1111/j.1349-7006.2009.01163.x Jiang Y, Wan YL, Wang ZJ et al (2004) Germline E-cadherin gene mutation screening in familial gastric cancer kindreds. Chinese J Surg 42:914–917 Kaurah P, MacMillan A, Boyd N et al (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297:2360–2372. https://doi.org/10.1001/jama.297.21.2360 Kim HC, Wheeler JMD, Kim JC et al (2000) The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut 47:262–267. https://doi.org/10.1136/gut.47.2.262 Kim S, Chung JW, Jeong TD et al (2013) Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients. Fam Cancer 12:503. https://doi.org/10.1007/s10689-012-9595-6 Kluijt I, Siemerink E, Ausems M et al (2012) CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer 131:367–376. https://doi.org/10.1002/ijc.26398 Kumar P, Henikoff S, Ng P (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081. https://doi.org/10.1038/nprot.2009.86 Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scandinavica 64:31–49. https://doi.org/10.1111/apm.1965.64.1.31 Lim S, Lee HS, Kim HS et al (2003) Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancers. Histopathology 42:128–136. https://doi.org/10.1046/j.1365-2559.2003.01546.x Lynch HT, Grady W, Suriano G, Huntsman D (2005) Gastric cancer: new genetic developments. J Surg Oncol 90:114–133. https://doi.org/10.1002/jso.20214 Maeta M, Yamashiro H, Oka A et al (1995) Gastric cancer in the young, with special reference to 14 pregnancy-associated cases: analysis based on 2,325 consecutive cases of gastric cancer. J Surg Oncol 58:191–195. https://doi.org/10.1002/jso.2930580310 More H, Humar B, Weber W et al (2007) Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 28:203. https://doi.org/10.1002/humu.9473 Oliveira C, Bordin M, Grehan N et al (2002) Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 19:510–517. https://doi.org/10.1002/humu.10068 Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. Ca Cancer J Clin 55:74–108. https://doi.org/10.3322/canjclin.55.2.74 Rogers WM, Dobo E, Norton J et al (2008) Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol 32:799–809. https://doi.org/10.1097/PAS.0b013e31815e7f1a Roviello F, Corso G, Pedrazzani C et al (2007) Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol 33:448–451. https://doi.org/10.1016/j.ejso.2006.10.028 Suriano G, Oliveira C, Ferreira P et al (2003a) Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Gen 12:575–582. https://doi.org/10.1093/hmg/ddg048 Suriano G, Oliveira MJ, Huntsman D et al (2003b) E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet 12:3007–3016. https://doi.org/10.1093/hmg/ddg316 Suriano G, Seixas S, Rocha J et al (2006) A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med 84:1023–1031. https://doi.org/10.1007/s00109-006-0091-z Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. Ca A Cancer J Clin 65:69–90. https://doi.org/10.3322/caac.21262 van der Post RS, Vogelaar IP, Carneiro F et al (2015a) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52:361–374. https://doi.org/10.1136/jmedgenet-2015-103094 van der Post RS, Vogelaar IP, Manders P et al (2015b) Accuracy of hereditary diffuse gastric cancer testing criteria and outcomes in patients with a germline mutation in CDH1. Gastroenterology 149:897–906. https://doi.org/10.1053/j.gastro.2015.06.003 van Roy F, Berx G (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65:3756–3788. https://doi.org/10.1007/s00018-008-8281-1 Windham TC, Termuhlen PM, Ajani JA et al (2002) Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome. J Surg Oncol 81:118–124. https://doi.org/10.1002/jso.10157 Yamada H, Shinmura K, Ito H et al (2011) Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population. Cancer Sci 102:1782–1788. https://doi.org/10.1111/j.1349-7006.2011.02038.x Zhang Y, Liu X, Fan Y et al (2006) Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. Int J Cancer 119:2592–2596. https://doi.org/10.1002/ijc.22206